Matrix metalloproteinase inhibition enhances the rate of nerve regeneration in vivo by promoting dedifferentiation and mitosis of supporting schwann cells.
Matrix metalloproteinase inhibition enhances the rate of nerve regeneration in vivo by promoting dedifferentiation and mitosis of supporting schwann cells.
复制标题
DOI:
10.1097/nen.0b013e3181d68d12
复制
发表时间:
2010-04
影响因子:
3.2
通讯作者:
Shubayev VI
中科院分区:
文献类型:
--
作者:
Liu H;Kim Y;Chattopadhyay S;Shubayev I;Dolkas J;Shubayev VI
Following peripheral nerve injury, Schwann cells (SCs) vigorously divide to survive and produce a sufficient number of cells to accompany regenerating axons. Matrix metalloproteinases (MMPs) have emerged as modulators of SC signaling and mitosis. Using a 5-bromo-2-deoxyuridine (BrdU) incorporation assay, we previously found that a broad-spectrum MMP inhibitor (MMPi), GM6001 (or Ilomastat), enhanced division of cultured primary SCs. Here, we tested the hypothesis that the ability of MMPi to stimulate SC mitosis may advance nerve regeneration in vivo. GM6001 administration immediately after rat sciatic nerve crush and daily thereafter produced increased nerve regeneration as determined by nerve pinch test and growth-associated protein-43 (GAP-43) expression. MMPi promoted endoneurial BrdU incorporation relative to vehicle control. The dividing cells were mainly SCs and were associated with GAP-43-positive regenerating axons. After MMP inhibition, myelin basic protein mRNA expression (determined by Taqman RT-qPCR) and active mitosis of myelin-forming SCs were reduced, indicating that MMPs suppressed their de-differentiation preceding mitosis. Intra-sciatic injection of the inhibitor of SC mitosis mitomycin suppressed nerve regrowth is reversed by MMPi, suggesting that its effect on axonal growth promotion depends on its pro-mitogenic action in SCs. These studies establish novel roles for MMPs in peripheral nerve repair via control of SC mitosis, differentiation and myelin protein mRNA expression.